Ossium Health Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
103
- Latest Deal Type
-
2ndary - Private
- Investors
-
26
Ossium Health General Information
Description
Developer of stem cell-based therapies designed to improve the health, vitality, and longevity of human beings through bioengineering. The company's therapies cure leukemia and other blood diseases, improve organ transplantation, treat radiation poisoning, and heal tissue damage, enabling healthcare professionals to improve a new paradigm for cell therapy development by bringing the deceased donor transplant ecosystem into the fight against diseases of the blood and immune systems.
Contact Information
Website
www.ossiumhealth.comCorporate Office
- 80 Tehama Street
- San Francisco, CA 94105
- United States
Corporate Office
- 80 Tehama Street
- San Francisco, CA 94105
- United States
Ossium Health Timeline
Ossium Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Secondary Transaction - Private | 01-Apr-2026 | Completed | Generating Revenue | |||
| 12. Later Stage VC | 01-Feb-2026 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series C) | 25-Jul-2023 | Completed | Generating Revenue | |||
| 10. Grant | 28-Apr-2023 | Completed | Generating Revenue | |||
| 9. Grant | 20-Sep-2021 | Completed | Clinical Trials - Phase 2 | |||
| 8. Later Stage VC (Series B) | 18-Mar-2021 | Completed | Clinical Trials - Phase 2 | |||
| 7. Grant | 18-Aug-2020 | Completed | Clinical Trials - Phase 2 | |||
| 6. Grant | 08-May-2019 | Completed | Clinical Trials - Phase 2 | |||
| 5. Early Stage VC (Series A) | 24-May-2018 | $10.4M | $10.4M | Completed | Clinical Trials - Phase 2 | |
| 4. Grant | 19-Apr-2018 | $573K | Completed | Clinical Trials - Phase 2 |
Ossium Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B-3 Prime | ||||||||
| Series B-2 Prime | ||||||||
| Series B-1 Prime | ||||||||
| Series B Prime | ||||||||
| Series B-3 | ||||||||
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series B | 155,038,754 | $0.000001 | 8% | $0.32 | $0.32 | $0.32 | 18.12% | |
| Series A-3 Prime | 21,930,077 | $0.000001 | 8% | $0.1 | $0.1 | $0.1 | 2.56% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ossium Health Comparisons
Industry
Financing
Details
Ossium Health Competitors (1)
One of Ossium Health’s competitors is Onconova Therapeutics, a Formerly VC-backed company based in Newtown, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Onconova Therapeutics | Formerly VC-backed | Newtown, PA |
Ossium Health Patents
Ossium Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026170062-A1 | Potency assay matrix for establishing consistency of manufactured cells | Pending | 06-Feb-2025 | ||
| WO-2025170935-A1 | Systems and methods for extraction and cryopreservation of bone marrow | Pending | 05-Feb-2024 | ||
| EP-4794743-A1 | Compositions and methods comprising tissue implants | Pending | 20-Oct-2023 | ||
| US-20260248858-A1 | Compositions and methods comprising tissue implants | Pending | 20-Oct-2023 | ||
| WO-2025085793-A1 | Compositions and methods comprising tissue implants | Inactive | 20-Oct-2023 | A61L27/3608 |
Ossium Health Signals
Ossium Health Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FemHealth Ventures | Venture Capital | Minority | ||
| Alumni Ventures | Venture Capital | Minority | ||
| CPMG | Growth/Expansion | Minority | ||
| California Institute for Regenerative Medicine | Government | |||
| National Institute of General Medical Sciences | Government |
Ossium Health FAQs
-
When was Ossium Health founded?
Ossium Health was founded in 2016.
-
Where is Ossium Health headquartered?
Ossium Health is headquartered in San Francisco, CA.
-
What is the size of Ossium Health?
Ossium Health has 103 total employees.
-
What industry is Ossium Health in?
Ossium Health’s primary industry is Drug Discovery.
-
Is Ossium Health a private or public company?
Ossium Health is a Private company.
-
What is Ossium Health’s current revenue?
The current revenue for Ossium Health is .
-
How much funding has Ossium Health raised over time?
Ossium Health has raised $126M.
-
Who are Ossium Health’s investors?
FemHealth Ventures, Alumni Ventures, CPMG, California Institute for Regenerative Medicine, and National Institute of General Medical Sciences are 5 of 26 investors who have invested in Ossium Health.
-
Who are Ossium Health’s competitors?
Onconova Therapeutics is a competitor of Ossium Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process